Bonjesta (20 mg + 20 mg) modified release tablets 20 pcs.

Bonjesta® (Bonjesta)

Modified-release tablets, 20 mg + 20 mgComposition per 1 tablet:

Doxylamine hydrobutartrate — 20 mg

Pyridoxine hydrochloride (vitamin B6) — 20 mg

Release form: Round-shaped, film-coated, modified-release tablets.

There are 10 tablets in a blister.

There are 20 tablets in a cardboard pack.

Pharmacological action:

The drug has an antiemetic effect due to a combination of:

Doxylamine (antihistamine component) — blocks H1-histamine receptors, has a sedative effectPyridoxine (B6) — reduces nausea, participates in amino acid metabolism

The modified release ensures a gradual intake of active substances and a long-lasting effect.Indications for use:

Nausea and vomiting in pregnant women (including severe form — hyperemesis gravidarum), when diet, dietary changes and uncorrectable factors have no effect.

Dosage regimen (typical): It is prescribed only by a doctor

Usually - 1 tablet at night, if necessary — additionally in the morning and afternoon (under the supervision of a doctor)Contraindications: Individual intolerance to the components

Severe liver/kidney dysfunction

Children's age

Simultaneous administration of MAO inhibitors

Side effects: Drowsiness, decreased concentration

Dry mouth, constipation

Dizziness

Storage conditions:

At a temperature not exceeding 25 °C, out of the reach of children

Pharmacy leave: By prescription.

Exeltis Poland Sp.z o.o

Szamocka 8

01-748 Warszawa

📦Find out about the delivery to your country on WhatsApp